Description
The Wondfo CA19-9 Rapid Quantitative Test is designed for quantitative measurement of the CA19-9 tumor marker in human serum, plasma, or whole blood. CA19-9 is a biomarker used in clinical assessment and monitoring, including in patients with pancreatic cancer.
Using a 75 μL sample volume, this assay provides quantitative results in approximately 10 minutes. Its compact test format supports efficient laboratory workflows.
Key Features
- Quantitative CA19-9 measurement
- 75 μL sample volume
- Results in approximately 10 minutes
- Serum, plasma, and whole blood compatibility
- Measuring range of 8–1,000 U/mL
- CE qualification
Technical Specifications
| Parameter | Details |
|---|---|
| Cat. No. | WW16P0001 |
| Test Item | CA19-9 |
| Specimen | Serum / Plasma / Whole Blood |
| Specimen Volume | 75 μL |
| Reaction Time | 10 minutes |
| Measuring Range | 8–1,000 U/mL |
| Qualification | CE |
Intended Use
For quantitative measurement of CA19-9 in human serum, plasma, or whole blood. It supports clinical assessment and monitoring as part of an overall diagnostic evaluation.
